Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 2/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11079293 | 1.00 | HTT (0.41) | HTTCA1CA2CA7CA9 | |
| SCHEMBL11069316 | 0.85 | PTPN1 (0.49) | HTTCA1CA2CA7CA9 | |
| SCHEMBL11069313 | 0.85 | PTPN1 (0.49) | HTTCA1CA2CA7CA9 | |
| SCHEMBL11071383 | 0.84 | HTT (0.40) | HTTCA1CA2CA7CA9 | |
| SCHEMBL11071406 | 0.84 | HTT (0.40) | HTTCA1CA2CA7CA9 | |
| SCHEMBL11080188 | 0.84 | HTT (0.40) | HTTCA1CA2CA7CA9 | |
| SCHEMBL11080186 | 0.84 | HTT (0.40) | HTTCA1CA2CA7CA9 | |
| SCHEMBL11367578 | 0.83 | HTT (0.39) | HTTCA1CA2CA7CA9 | |
| Formaldehyde SCHEMBL11076914 | 0.82 | KDM1A (0.42) | HTTFOLH1SLC1A1 | |
| SCHEMBL11081443 | 0.82 | FOLH1 (0.45) | HTTCA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0021775-B1 | SYNTHESIS OF 1RS,4SR,5RS-4-(4,8-DIMETHYL-5-HYDROXY-7-NONEN-1-YL)-4-METHYL-3,8-DIOXABICYCLO(3.2.1)OCTANE-1-ACETIC ACID AND INTERMEDIATES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1984-09-26 | — | — | EP | disclosed |